Case number 1:19-cv-02313
Janssen Pharmaceuticals, Inc. et al v. Pharmascience Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 3, 2020 | 7 | Patent/Trademark Report to Commissioner (1) |
| Mar 3, 2020 | 7 | Notice of Dismissal (1) |
| Mar 3, 2020 | 7 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,439,906. (Attachments: # (1) Notice of Dismissal)(fms) |
| Mar 2, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [6]. (fms) |
| Mar 2, 2020 | 6 | Notice of Voluntary Dismissal (1) Docket Text: NOTICE of Voluntary Dismissal by Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. as to All Defendants, without Prejudice. (Balick, Steven) |
| Dec 26, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Dec 20, 2019 | 1 | Complaint (15) |
| Dec 20, 2019 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (lak) |
| Dec 20, 2019 | 1 | Exhibit A (25) |
| Dec 20, 2019 | 1 | Civil Cover Sheet (2) |
| Dec 20, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Dec 20, 2019 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/8/2019. Date of Expiration of Patent: 1/26/2031.Thirty Month Stay Deadline: 5/8/2022. (lak) |
| Dec 20, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,439,906. (lak) |
| Dec 20, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. (lak) |
| Dec 20, 2019 | 1 | Main Document (15) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Mallinckrodt plc, Pharmascience Inc., SpecGx LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2807259.) - filed by Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet) (lak) |
| Dec 20, 2019 | 1 | Complaint* (1) |
